Headline News about Urogen Pharma Ltd
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://www.investors.com/wp-content/uploads/2017/05/IRU4.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/06/18/movers-image_12.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/06/14/Image45.jpeg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2024/06/Stock-UroGenpharma-01-adobe.jpg)
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For UroGen Pharma
March 13, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Recap: UroGen Pharma Q3 Earnings
November 14, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/03/25/image30.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](/next-assets/images/schema-image-default.png)
Preview: UroGen Pharma's Earnings
November 13, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for UroGen Pharma
October 04, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.jpeg?width=1200&height=800&fit=crop)
Where UroGen Pharma Stands With Analysts
July 31, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Recap: UroGen Pharma Q1 Earnings
May 11, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/ep_us_feature_image_2307.jpeg?width=1200&height=800&fit=crop)
UroGen Pharma Earnings Preview
March 15, 2023
Via Benzinga
UroGen Pharma's Return On Capital Employed Overview
December 20, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/israel-hama-war-shutter3_5.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/israel_war_shutter2.jpeg?width=1200&height=800&fit=crop)
Cathie Wood's ARK Israel Innovative Tech ETF Braces For Impact Amid Regional Warfare: 10 Stocks To Watch
October 09, 2023
Via Benzinga
Topics
ETFs
![](https://media.bespokepremium.com/uploads/2023/08/r3k.png)
![](https://g.foolcdn.com/editorial/images/741739/healthcare-lab-treatment-research-scientist-1.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/28/benzinga_stock_whisper_index.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/08/17/image15.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/28/enphase_energy_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/07/27/urgn.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_1856.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_177.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Benzinga's Top Ratings Upgrades, Downgrades For February 8, 2023
February 08, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.